Title : Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.

Pub. Date : 2009 Feb

PMID : 19070393






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Entecavir- and lamivudine-treated patients who achieved a protocol-defined "Virological Response" (HBV-DNA<0.7MEq/mL but ALT1.25xULN) at 48 weeks, continued blinded treatment until they achieved Response or 96 weeks, whichever came first. entecavir glutamic--pyruvic transaminase Homo sapiens